Core Viewpoint - Tailong Pharmaceutical (600222.SH) has received a registration notice from the China Interbank Market Dealers Association for its technology innovation bonds, indicating a strategic move to raise funds through short-term financing [1] Group 1: Registration Details - The company has registered for a super short-term financing bond with a total amount of 800 million yuan [1] - The registration is valid for two years from the date of the notice and is underwritten by China Minsheng Banking Corp and Shanghai Pudong Development Bank [1] - The company can issue the bonds in installments during the registration period and must file with the association prior to any issuance [1]